Suppr超能文献

药物性肺血管疾病——机制与临床模式

Drug-induced pulmonary vascular disease--mechanisms and clinical patterns.

作者信息

Kumar K, Holden W E

出版信息

West J Med. 1986 Sep;145(3):343-9.

Abstract

An extensive vascular surface area places the lungs at risk for damage by blood-borne drugs. Drug-induced pulmonary vascular disease may present clinically as acute pulmonary edema, pulmonary edema followed by diffuse interstitial lung disease, pulmonary vascular occlusion, pulmonary hypertension or hemorrhage. It is important to recognize these reactions as drug-related because many are reversible with discontinuation of the drug and supportive therapy. Failure to recognize drug-induced pulmonary vascular disease can lead to significant morbidity and, in some cases, death.

摘要

广泛的血管表面积使肺脏有受到血源药物损害的风险。药物性肺血管疾病在临床上可能表现为急性肺水肿、肺水肿后继而出现弥漫性间质性肺病、肺血管阻塞、肺动脉高压或出血。认识到这些反应与药物有关很重要,因为许多反应在停用药物和进行支持性治疗后是可逆的。未能识别药物性肺血管疾病可导致严重的发病情况,在某些情况下还会导致死亡。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验